Sam Cytryn retweetledi
He did! First day as an attending under his belt. Congratulations @Sam_Cytryn ! It gets easier after today 😉@MSKCancerCenter @MSK_DeptOfMed looking forward to opening more GEC studies in #Westchester.
English
Sam Cytryn
2 posts
Sam Cytryn
@Sam_Cytryn
Chief Fellow, Medical Oncology and Hematology at Memorial Sloan Kettering Cancer Center
New York, NY Katılım Ocak 2022
87 Takip Edilen161 Takipçiler
Sam Cytryn retweetledi
Wrote this IIT with @YJanjigianMD when I was a fellow and great to see this phase 2 study now completed. FOLFOX plus regorafenib and nivolumab for advanced EG cancer. ORR 76% and 6-month PFS 71%. Nice work @Sam_Cytryn and team!
The Lancet Oncology@TheLancetOncol
NOW OF: A US single-arm, single-centre, ph 2 trial assesses the safety and activity of regorafenib in combination with nivolumab and chemotherapy in the first-line treatment of advanced oesophagogastric adenocarcinoma. #gicsm thelancet.com/journals/lanon…
Manhattan, NY 🇺🇸 English